Related posts

Markets sell off after recent highsTop Insurance Company Stocks to Buy in 2019
Investor Insights

This summary was created by AI, based on 2 opinions in the last 12 months.

Experts have mixed opinions on Metlife. One expert believes it could be a good time for investors due to its low valuation, while another recommends covering the position as the stock has triggered its stop. The stock is deemed fundamentally average, but could be volatile. There are better options available for investors.

Consensus
Mixed
Valuation
Fair Value
DON'T BUY
Metlife

Does not own shares. Financial services and insurance. Valuation is low and could be good time for investors. Does not own shares. Fundamentally a 6/10. Could be volatile. Better options out there for investors. 

insurance
premium

This is a Panic-proof Portfolio opinion which is available only for Premium members

Curated by Michael O'Reilly since 2020.
1550+ opinions with 4.81 rating (one of the best performing expert).

PAST TOP PICK
Metlife
(A Top Pick Sep 27/22, Up 7.4%)Stockchase Research Editor: Michael O’Reilly

Our PAST TOP PICK with MET has triggered its stop at $65.  To remain disciplined, we recommend covering the position at this time.

insurance
premium

This is a Panic-proof Portfolio opinion which is available only for Premium members

Curated by Michael O'Reilly since 2020.
1550+ opinions with 4.81 rating (one of the best performing expert).

PAST TOP PICK
Metlife
(A Top Pick Sep 27/22, Up 27.2%)Stockchase Research Editor: Michael O'Reilly Our PAST TOP PICK with MET has achieved its target at $77. To remain disciplined, we recommend covering half the position and trailing up the stop loss (from $62) to $67. If triggered, this would result in a net investment gain of 18%.
insurance
HOLD
Metlife
Switch from Canadian insurers to MET? Hit a new high today. Likes it. Financials are at a historical discount. Likes banks, insurers and diversified financials. He wouldn't switch, as some Canadian valuations are quite cheap. Nice dividend of 2.6%.
insurance
HOLD
Metlife
Model price of $87.26, 18% upside. Market really liked its write down on balance sheet or spinoff. Likes it here. Turned itself around. Will probably go to $80, and he'll evaluate it there.
insurance
premium

This is a Panic-proof Portfolio opinion which is available only for Premium members

Curated by Michael O'Reilly since 2020.
1550+ opinions with 4.81 rating (one of the best performing expert).

PAST TOP PICK
Metlife
(A Top Pick Sep 27/22, Up 22.4%)Stockchase Research Editor: Michael O'Reilly Our PAST TOP PICK with MET is progressing well. To remain disciplined, we now recommend trailing up the stop (from $52.50) to $62.00.
insurance
premium

This is a Panic-proof Portfolio opinion which is available only for Premium members

Curated by Michael O'Reilly since 2020.
1550+ opinions with 4.81 rating (one of the best performing expert).

TOP PICK
Metlife
Stockchase Research Editor: Michael O'Reilly This world leader in insurance and benefits is a TOP PICK. The company just announced a deal along with PRU to assume the $16 billion pension obligation of IBM -- right up its alley. We like the value here as the company is trading under book value, just beat analyst earnings expectations, and is projected to trade 7x earnings. It has managed to increase cash reserves, while aggressively retiring debt and buying back shares. Its dividend is backed by a payout ratio under 50% of cash flow. We recommend placing a stop loss at $52.50, looking to achieve $77 -- upside potential of 25%. Yield 3.2% (Analysts’ price target is $77.25)
insurance
BUY
Metlife
The insurers have been in fire, like MetLife. He believes rates will go higher, so definitely stick with them.
insurance
DON'T BUY
Metlife
It's fine, but he does not likes financials (or energy). He just likes MET's yield and that's it.
insurance
COMMENT
Metlife

AIG-N vs. MET-N. AIG-N has been recapitalizing since the disaster of the financial crisis. MET-N did not suffer these issues. The life business is in pretty decent shape but he prefers Canadian lifecos. (Analysts’ price target is $55.57)

insurance
BUY
Metlife
It’s pretty cheap, trading at 8.1 times. Their earnings in July were double year over year and beat expectations. They are growing globally and it’s a safe name with a low valuation. Couldn’t go wrong with this choice in the long term.
insurance
WAIT
Metlife
MET vs. BAC. Dynamics of the two are different, so hard to compare. FMV potential of both is huge. But the market won't go, because interest rates are falling. Aren't any drivers to escalate earnings. Very cheap, but who knows when they're going to pop? (Analysts’ price target is $53.19)
insurance
DON'T BUY
Metlife
The balance sheet is impaired and there should be write-offs, which he hasn't seen. He sees 32% upside with a $64 model price, but he'd be happy seeing this at $53.80. He would recommend this stock above this price. He has recommended MET before, but MET just can't get going. The balance sheet is ugly. Also, if interest rates fall to zero, all insurance companies will get hit.
insurance
PAST TOP PICK
Metlife
(A Top Pick Mar 29/18, Up 3%) Slow or flar growth this and next year, but they are buying back stock. He sees 9% EPS growth this year. Their US retirement portfolio has been doing well. It's cheap at 8x PE and paying almost a 4% dividend. It's been stagnant for many years, but it has tailwinds of lower taxes and volume growth. They're growing in Asia and Europe.
insurance
DON'T BUY
Metlife
Metlife vs. Prudential vs US banks Both are high quality and international. Strong. He doesn't love lifecos now, because there's a lot going on in health, such as the prevalance of diabetes. He wants to see higher interest rates which can benefit lifecos. As for banks, he'd stay away. The rates and yield curve have flattened. Met are doing the right thing, like a nice dividend and a big share buybacks. It isn't expensive and doing 10% earnings growth, but there are greener pastures elsewhere.
insurance
Showing 1 to 15 of 110 entries

Metlife(MET-N) Rating

Ranking : 3 out of 5

Bullish - Buy Signals / Votes : 1

Neutral - Hold Signals / Votes : 0

Bearish - Sell Signals / Votes : 1

Total Signals / Votes : 2

Stockchase rating for Metlife is calculated according to the stock experts' signals. A high score means experts mostly recommend to buy the stock while a low score means experts mostly recommend to sell the stock.

Metlife(MET-N) Frequently Asked Questions

What is Metlife stock symbol?

Metlife is a American stock, trading under the symbol MET-N on the New York Stock Exchange (MET). It is usually referred to as NYSE:MET or MET-N

Is Metlife a buy or a sell?

In the last year, 2 stock analysts published opinions about MET-N. 1 analyst recommended to BUY the stock. 1 analyst recommended to SELL the stock. The latest stock analyst recommendation is . Read the latest stock experts' ratings for Metlife.

Is Metlife a good investment or a top pick?

Metlife was recommended as a Top Pick by on . Read the latest stock experts ratings for Metlife.

Why is Metlife stock dropping?

Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.

Is Metlife worth watching?

2 stock analysts on Stockchase covered Metlife In the last year. It is a trending stock that is worth watching.

What is Metlife stock price?

On 2024-02-28, Metlife (MET-N) stock closed at a price of $69.485.